Patent · US Active

Process for making compounds for use in the treatment of cancer

US10239858B2 · kind B2 · utility

3Cited by

7References

7Claims

0Family size

Assignees

Exelixis, Inc. · US
Genentech, Inc. · US

Inventors

Sriram Naganathan · San Jose, US
Nathan Guz · Rue de l'Église, US
Matthew Pfeiffer · Salt Lake City, US
C. Gregory Sowell · South San Francisco, US
Tracy Bostick · Buchans, CA
Jason Yang · Pleasanton, US
Amit Srivastava · Aiken, US
Neel K. Anand · Burlingame, US

Key dates

Filing date	Aug 25, 2017
Grant date	Mar 26, 2019
Priority date	—
Expiry date	Aug 25, 2037

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Disclosed herein is a process of making a compound of formula I The compound of formula I is an inhibitor of MEK and thus can be used to treat cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.